Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ISRG vs NVDA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+134.6%
NVDA
NVIDIA Corporation

Semiconductors

TechnologyNASDAQ • US
Market Cap$5.05T
5Y Perf.+2147.4%

ISRG vs NVDA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ISRG logoISRG
NVDA logoNVDA
IndustryMedical - Instruments & SuppliesSemiconductors
Market Cap$160.44B$5.05T
Revenue (TTM)$10.58B$215.94B
Net Income (TTM)$2.98B$120.07B
Gross Margin66.3%71.1%
Operating Margin30.5%60.4%
Forward P/E43.8x25.1x
Total Debt$303M$11.41B
Cash & Equiv.$3.37B$10.61B

ISRG vs NVDALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ISRG
NVDA
StockMay 20May 26Return
Intuitive Surgical,… (ISRG)100234.6+134.6%
NVIDIA Corporation (NVDA)1002247.4+2147.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ISRG vs NVDA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NVDA leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Intuitive Surgical, Inc. is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 1.02
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.02, current ratio 4.87x
Best for: income & stability and sleep-well-at-night
NVDA
NVIDIA Corporation
The Growth Play

NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
  • 234.3% 10Y total return vs ISRG's 5.6%
  • PEG 0.26 vs ISRG's 2.01
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthNVDA logoNVDA65.5% revenue growth vs ISRG's 20.5%
ValueNVDA logoNVDALower P/E (25.1x vs 43.8x), PEG 0.26 vs 2.01
Quality / MarginsNVDA logoNVDA55.6% margin vs ISRG's 28.2%
Stability / SafetyISRG logoISRGBeta 1.02 vs NVDA's 1.73, lower leverage
DividendsNVDA logoNVDA0.0% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)NVDA logoNVDA+82.9% vs ISRG's -14.8%
Efficiency (ROA)NVDA logoNVDA58.1% ROA vs ISRG's 14.8%, ROIC 81.8% vs 15.0%

ISRG vs NVDA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
NVDANVIDIA Corporation
FY 2026
Data Center
89.7%$193.7B
Gaming
7.4%$16.0B
Professional Visualization
1.5%$3.2B
Automotive
1.1%$2.3B
OEM And Other
0.3%$619M

ISRG vs NVDA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNVDALAGGINGISRG

Income & Cash Flow (Last 12 Months)

NVDA leads this category, winning 6 of 6 comparable metrics.

NVDA is the larger business by revenue, generating $215.9B annually — 20.4x ISRG's $10.6B. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to ISRG's 28.2%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
RevenueTrailing 12 months$10.6B$215.9B
EBITDAEarnings before interest/tax$3.8B$133.2B
Net IncomeAfter-tax profit$3.0B$120.1B
Free Cash FlowCash after capex$2.8B$96.7B
Gross MarginGross profit ÷ Revenue+66.3%+71.1%
Operating MarginEBIT ÷ Revenue+30.5%+60.4%
Net MarginNet income ÷ Revenue+28.2%+55.6%
FCF MarginFCF ÷ Revenue+26.8%+44.8%
Rev. Growth (YoY)Latest quarter vs prior year+23.0%+73.2%
EPS Growth (YoY)Latest quarter vs prior year+18.8%+97.8%
NVDA leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

NVDA leads this category, winning 5 of 7 comparable metrics.

At 42.4x trailing earnings, NVDA trades at a 26% valuation discount to ISRG's 57.4x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.44x vs ISRG's 2.64x — a lower PEG means you pay less per unit of expected earnings growth.

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
Market CapShares × price$160.4B$5.05T
Enterprise ValueMkt cap + debt − cash$157.4B$5.05T
Trailing P/EPrice ÷ TTM EPS57.40x42.38x
Forward P/EPrice ÷ next-FY EPS est.43.84x25.09x
PEG RatioP/E ÷ EPS growth rate2.64x0.44x
EV / EBITDAEnterprise value multiple43.44x37.89x
Price / SalesMarket cap ÷ Revenue15.94x23.37x
Price / BookPrice ÷ Book value/share9.13x32.26x
Price / FCFMarket cap ÷ FCF64.42x52.21x
NVDA leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — ISRG and NVDA each lead in 4 of 8 comparable metrics.

NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $17 for ISRG. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVDA's 0.07x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs NVDA's 4/9, reflecting solid financial health.

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
ROE (TTM)Return on equity+16.9%+76.3%
ROA (TTM)Return on assets+14.8%+58.1%
ROICReturn on invested capital+15.0%+81.8%
ROCEReturn on capital employed+16.5%+97.2%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage0.02x0.07x
Net DebtTotal debt minus cash-$3.1B$807M
Cash & Equiv.Liquid assets$3.4B$10.6B
Total DebtShort + long-term debt$303M$11.4B
Interest CoverageEBIT ÷ Interest expense545.03x
Evenly matched — ISRG and NVDA each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

NVDA leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in NVDA five years ago would be worth $143,108 today (with dividends reinvested), compared to $16,086 for ISRG. Over the past 12 months, NVDA leads with a +82.9% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors NVDA at 92.4% vs ISRG's 14.2% — a key indicator of consistent wealth creation.

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
YTD ReturnYear-to-date-19.6%+10.0%
1-Year ReturnPast 12 months-14.8%+82.9%
3-Year ReturnCumulative with dividends+49.0%+612.7%
5-Year ReturnCumulative with dividends+60.9%+1331.1%
10-Year ReturnCumulative with dividends+556.9%+23433.1%
CAGR (3Y)Annualised 3-year return+14.2%+92.4%
NVDA leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and NVDA each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than NVDA's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 95.8% from its 52-week high vs ISRG's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
Beta (5Y)Sensitivity to S&P 5001.02x1.73x
52-Week HighHighest price in past year$603.88$216.80
52-Week LowLowest price in past year$427.84$110.82
% of 52W HighCurrent price vs 52-week peak+74.8%+95.8%
RSI (14)Momentum oscillator 0–10042.250.8
Avg Volume (50D)Average daily shares traded1.8M166.2M
Evenly matched — ISRG and NVDA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ISRG as "Buy" and NVDA as "Buy". Consensus price targets imply 37.8% upside for ISRG (target: $623) vs 34.3% for NVDA (target: $279).

MetricISRG logoISRGIntuitive Surgica…NVDA logoNVDANVIDIA Corporation
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60$278.83
# AnalystsCovering analysts5579
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$0.04
Buyback YieldShare repurchases ÷ mkt cap+1.4%+0.8%
Insufficient data to determine a leader in this category.
Key Takeaway

NVDA leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.

Best OverallNVIDIA Corporation (NVDA)Leads 3 of 6 categories
Loading custom metrics...

ISRG vs NVDA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ISRG or NVDA a better buy right now?

For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.

5% revenue growth year-over-year, versus 20. 5% for Intuitive Surgical, Inc. (ISRG). NVIDIA Corporation (NVDA) offers the better valuation at 42. 4x trailing P/E (25. 1x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ISRG or NVDA?

On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 42.

4x versus Intuitive Surgical, Inc. at 57. 4x. On forward P/E, NVIDIA Corporation is actually cheaper at 25. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 26x versus Intuitive Surgical, Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ISRG or NVDA?

Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1331%, compared to +60.

9% for Intuitive Surgical, Inc. (ISRG). Over 10 years, the gap is even starker: NVDA returned +234. 3% versus ISRG's +554. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ISRG or NVDA?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus NVIDIA Corporation's 1. 73β — meaning NVDA is approximately 69% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 7% for NVIDIA Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — ISRG or NVDA?

By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.

5% versus 20. 5% for Intuitive Surgical, Inc. (ISRG). On earnings-per-share growth, the picture is similar: NVIDIA Corporation grew EPS 66. 7% year-over-year, compared to 22. 6% for Intuitive Surgical, Inc.. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ISRG or NVDA?

NVIDIA Corporation (NVDA) is the more profitable company, earning 55.

6% net margin versus 28. 4% for Intuitive Surgical, Inc. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus 29. 3% for ISRG. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ISRG or NVDA more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 26x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 25. 1x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 18. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 8% to $622. 60.

08

Which pays a better dividend — ISRG or NVDA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is ISRG or NVDA better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). NVIDIA Corporation (NVDA) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, NVDA: +234. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ISRG and NVDA?

These companies operate in different sectors (ISRG (Healthcare) and NVDA (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

NVDA

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 36%
  • Net Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ISRG and NVDA on the metrics below

Revenue Growth>
%
(ISRG: 23.0% · NVDA: 73.2%)
Net Margin>
%
(ISRG: 28.2% · NVDA: 55.6%)
P/E Ratio<
x
(ISRG: 57.4x · NVDA: 42.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.